Eris Lifesciences
Important Information/ Views
December 4, 2021
Eris has formed a JV with MJ Biopharm for this purpose. Key points to note – Eris will hold 70% of the JV and MJ 30%. MJ is also getting ... Read more
Do you have something important to share about the Company?
Subscribe
Login
0 Comments
Inline Feedbacks
View all comments